BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15555827)

  • 1. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
    Marrie TJ
    Infect Dis Clin North Am; 2004 Dec; 18(4):829-41. PubMed ID: 15555827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atypical pathogens of pneumonia acquired in ambulant persons].
    Tuschy P; Lorenz J
    Dtsch Med Wochenschr; 2004 Mar; 129(10):503-8. PubMed ID: 14986239
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of atypical pathogens of community-acquired pneumonia.
    Plouffe JF
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S35-9. PubMed ID: 10984326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of atypical pathogens in community-acquired pneumonia.
    Gupta SK; Sarosi GA
    Med Clin North Am; 2001 Nov; 85(6):1349-65, vii. PubMed ID: 11680106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team.
    Mundy LM; Oldach D; Auwaerter PG; Gaydos CA; Moore RD; Bartlett JG; Quinn TC
    Chest; 1998 May; 113(5):1201-6. PubMed ID: 9596295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
    Dunbar LM; Khashab MM; Kahn JB; Zadeikis N; Xiang JX; Tennenberg AM
    Curr Med Res Opin; 2004 Apr; 20(4):555-63. PubMed ID: 15119993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired pneumonia: role of atypical organisms.
    Cosentini R; Tarsia P; Blasi F; Roma E; Allegra L
    Monaldi Arch Chest Dis; 2001 Dec; 56(6):527-34. PubMed ID: 11980285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atypical pneumonias: clinical diagnosis and importance.
    Cunha BA
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():12-24. PubMed ID: 16669925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein for discriminating treatment failure from slow responding pneumonia.
    Ruiz-González A; Falguera M; Porcel JM; Martínez-Alonso M; Cabezas P; Geijo P; Boixeda R; Dueñas C; Armengou A; Capdevila JA; Serrano R
    Eur J Intern Med; 2010 Dec; 21(6):548-52. PubMed ID: 21111942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
    Ouchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analysis of guidelines for the treatment of community-acquired pneumonias].
    Rodríguez de Castro F
    Arch Bronconeumol; 1999 Jun; 35(6):253-6. PubMed ID: 10410203
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical pathogen pneumonia.
    Lieberman D; Lieberman D
    Curr Opin Pulm Med; 1997 Mar; 3(2):111-5. PubMed ID: 9193855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotherapy in children with atypical bacterial infections].
    Haas H
    Arch Pediatr; 2005 Apr; 12 Suppl 1():S45-8. PubMed ID: 15893238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chlamydia pneumoniae and other Chlamydia species in community-acquired pneumonia].
    Ruiz Carmona M; Soler Polcar N; Torres Martí A
    Rev Clin Esp; 1998 Sep; 198 Suppl 1():30-4. PubMed ID: 9835771
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlamydia pneumoniae and Mycoplasma pneumoniae.
    Blasi F; Tarsia P; Aliberti S; Cosentini R; Allegra L
    Semin Respir Crit Care Med; 2005 Dec; 26(6):617-24. PubMed ID: 16388430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription of macrolides in community-acquired pneumonia: science or art?
    Rello J
    Chest; 1998 May; 113(5):1155-8. PubMed ID: 9596285
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosing and treating atypical pneumonia.
    Smith G; Hosker H
    Practitioner; 2001 Sep; 245(1626):736-40, 742, 746. PubMed ID: 11584587
    [No Abstract]   [Full Text] [Related]  

  • 20. Legionnaires' disease and pneumonia. Beware the temptation to underestimate this "exotic" cause of infection.
    Akbas E; Yu VL
    Postgrad Med; 2001 May; 109(5):135-8, 141-2, 147. PubMed ID: 11381664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.